开发和验证用于识别胃肠道癌诊断评估延迟的触发算法。

Development and Validation of Trigger Algorithms to Identify Delays in Diagnostic Evaluation of Gastroenterological Cancer.

机构信息

Houston Veterans Affairs Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas; Department of Medicine, Baylor College of Medicine, Houston, Texas.

Houston Veterans Affairs Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas; Department of Medicine, Baylor College of Medicine, Houston, Texas.

出版信息

Clin Gastroenterol Hepatol. 2018 Jan;16(1):90-98. doi: 10.1016/j.cgh.2017.08.007. Epub 2017 Aug 10.

Abstract

BACKGROUND & AIMS: Colorectal cancer (CRC) and hepatocellular cancer (HCC) are common causes of death and morbidity, and patients benefit from early detection. However, delays in follow-up of suspicious findings are common, and methods to efficiently detect such delays are needed. We developed, refined, and tested trigger algorithms that identify patients with delayed follow-up evaluation of findings suspicious of CRC or HCC.

METHODS

We developed and validated two trigger algorithms that detect delays in diagnostic evaluation of CRC and HCC using laboratory, diagnosis, procedure, and referral codes from the Department of Veteran Affairs National Corporate Data Warehouse. The algorithm initially identified patients with positive test results for iron deficiency anemia or fecal immunochemical test (for CRC) and elevated α-fetoprotein results (for HCC). Our algorithm then excluded patients for whom follow-up evaluation was unnecessary, such as patients with a terminal illness or those who had already completed a follow-up evaluation within 60 days. Clinicians reviewed samples of both delayed and nondelayed records, and review data were used to calculate trigger performance.

RESULTS

We applied the algorithm for CRC to 245,158 patients seen from January 1, 2013, through December 31, 2013 and identified 1073 patients with delayed follow up. In a review of 400 randomly selected records, we found that our algorithm identified patients with delayed follow-up with a positive predictive value of 56.0% (95% CI, 51.0%-61.0%). We applied the algorithm for HCC to 333,828 patients seen from January 1, 2011 through December 31, 2014, and identified 130 patients with delayed follow-up. During manual review of all 130 records, we found that our algorithm identified patients with delayed follow-up with a positive predictive value of 82.3% (95% CI, 74.4%-88.2%). When we extrapolated the findings to all patients with abnormal results, the algorithm identified patients with delayed follow-up evaluation for CRC with 68.6% sensitivity (95% CI, 65.4%-71.6%) and 81.1% specificity (95% CI, 79.5%-82.6%); it identified patients with delayed follow-up evaluation for HCC with 89.1% sensitivity (95% CI, 81.8%-93.8%) and 96.5% specificity (95% CI, 94.8%-97.7%). Compared to nonselective methods, use of the algorithm reduced the number of records required for review to identify a delay by more than 99%.

CONCLUSIONS

Using data from the Veterans Affairs electronic health record database, we developed an algorithm that greatly reduces the number of record reviews necessary to identify delays in follow-up evaluations for patients with suspected CRC or HCC. This approach offers a more efficient method to identify delayed diagnostic evaluation of gastroenterological cancers.

摘要

背景与目的

结直肠癌(CRC)和肝细胞癌(HCC)是常见的死亡和发病原因,患者受益于早期发现。然而,对可疑发现的随访延迟很常见,需要有效的方法来检测这种延迟。我们开发、改进和测试了触发算法,以识别出 CRC 或 HCC 可疑发现的随访评估延迟的患者。

方法

我们使用退伍军人事务部国家企业数据仓库中的实验室、诊断、程序和转诊代码开发并验证了两种触发算法,以检测 CRC 和 HCC 诊断评估延迟。该算法最初确定了铁缺乏性贫血或粪便免疫化学试验(用于 CRC)和甲胎蛋白升高(用于 HCC)阳性结果的患者。我们的算法随后排除了不需要进行随访评估的患者,例如患有绝症或在 60 天内已完成随访评估的患者。临床医生审查了延迟和非延迟记录的样本,使用审查数据计算触发性能。

结果

我们将用于 CRC 的算法应用于 2013 年 1 月 1 日至 12 月 31 日期间就诊的 245158 名患者,并确定了 1073 名有延迟随访的患者。在对随机选择的 400 份记录进行审查后,我们发现我们的算法对延迟随访的患者的阳性预测值为 56.0%(95%CI,51.0%-61.0%)。我们将用于 HCC 的算法应用于 2011 年 1 月 1 日至 2014 年 12 月 31 日就诊的 333828 名患者,并确定了 130 名有延迟随访的患者。在对所有 130 份记录进行手动审查期间,我们发现我们的算法对延迟随访的患者的阳性预测值为 82.3%(95%CI,74.4%-88.2%)。当我们将研究结果外推到所有异常结果的患者时,该算法对 CRC 有延迟随访评估的患者的敏感性为 68.6%(95%CI,65.4%-71.6%),特异性为 81.1%(95%CI,79.5%-82.6%);对 HCC 有延迟随访评估的患者的敏感性为 89.1%(95%CI,81.8%-93.8%),特异性为 96.5%(95%CI,94.8%-97.7%)。与非选择性方法相比,使用该算法将识别延迟所需的记录审查数量减少了 99%以上。

结论

我们使用退伍军人事务部电子健康记录数据库中的数据开发了一种算法,大大减少了识别疑似 CRC 或 HCC 患者随访评估延迟所需的记录审查数量。这种方法提供了一种更有效的方法来识别胃肠道癌症的诊断评估延迟。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索